Idexx Laboratories (IDXX) Non-Current Deffered Revenue (2009 - 2026)

Idexx Laboratories' Non-Current Deffered Revenue history runs 18 years deep, the most recent figure standing at $32.3 million for Q1 2026.

• In Q1 2026, Non-Current Deffered Revenue rose 20.49% year-over-year to $32.3 million; the TTM figure through Mar 2026 stood at $32.3 million (up 20.49% YoY), while the FY2025 annual figure was $32.2 million, up 19.44% from the prior year.
• Non-Current Deffered Revenue was $32.3 million for Q1 2026 at Idexx Laboratories, roughly flat from $32.2 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $39.2 million in Q1 2022 to a low of $26.8 million in Q3 2024.
• Historically, Non-Current Deffered Revenue has averaged $30.6 million across 5 years, with a median of $30.4 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Non-Current Deffered Revenue slipped 25.04% in 2022, then gained 20.49% in 2026.
• A 5-year view of Non-Current Deffered Revenue shows it stood at $30.9 million in 2022, then declined by 7.55% to $28.5 million in 2023, then fell by 5.59% to $26.9 million in 2024, then grew by 19.44% to $32.2 million in 2025, then climbed by 0.42% to $32.3 million in 2026.
• The last three Non-Current Deffered Revenue figures came in at $32.3 million (Q1 2026), $32.2 million (Q4 2025), and $31.1 million (Q3 2025), per Business Quant data.